Meanwhile, numerous studies have associated mutations in moderate-penetrance genes, including PALB2, ATM, CHEK2, BRIP1, with increased breast cancer risk of two to four-fold compared to the 10% risk of the general population [5]. This evidence concerns the gene ATM and breast carcinoma.